Survival of patients removed from the heart transplant waiting list

Area of Science:

• Cardiology
• Heart Failure Management
• Transplantation Medicine

Background:

• End-stage heart failure carries a high mortality risk without cardiac transplantation.
• Optimal medical therapy is a cornerstone in managing advanced heart failure.
• Cardiac transplant waiting lists involve careful patient selection and monitoring.

Purpose of the Study:

• To evaluate the survival outcomes of patients removed from the cardiac transplant waiting list.
• To identify predictors of mortality in this patient cohort.
• To assess the impact of clinical improvement on long-term survival.

Main Methods:

• Retrospective review of 27 patients removed from a cardiac transplant waiting list (1999-2001).
• Patients categorized into two groups: clinical improvement (Group A) and deterioration (Group B).
• Analysis of functional status, echocardiographic data, and survival rates.

Main Results:

• Group A (n=18) demonstrated 100% 3-year survival, with improved functional status and left ventricular function.
• Group B (n=9) showed a 44% 3-year survival rate.
• Clinical improvement was strongly associated with significantly better survival outcomes.

Conclusions:

• Patients with end-stage heart failure responding well to medical therapy exhibit excellent long-term survival.
• Close monitoring and a low threshold for removing patients with persistent clinical improvement from the transplant list are recommended.
• This strategy may optimize resource allocation and improve patient outcomes.